Un aporte de Leila Mir Candal

Quisiera compartir con Uds un artículo que acabo de leer en NEJM 6 de septiembre escrito por Jeffrey Drazen: Volunteers at risk. Y como bien señala Luis es la vulneración del/los vulnerable/s. Aunque el título les parezca que remite a una toma en consideración de los voluntarios, el comentario termina retrotrayéndonos al pasado pre-Nuremberg. Dice así : que la salud futura de la población mundial demanda que los efectos adversos no se conviertan en una limitante para el progreso médico Debemos tratar a aquellos en riesgo con respeto y cuidado pero el trabajo debe continuar.
¿Qué les parece?
Cariños
Leila

 

Volunteers at Risk

Jeffrey M. Drazen, M.D.

Clinical research can be a risky endeavor. In this issue of the Journal, Suntharalingam et al. describe the events that occurred when six healthy

volunteers received a dose (0.1 mg per kilogram of body weight) of TGN1412 — a superagonistic humanized monoclonal antibody that stimulates

and expands T-cell populations independently of the ligation of the T-cell receptor. In all six patients, the cytokine-release syndrome developed,

including multiorgan failure. Two of the patients required mechanical ventilation, and all received renal-replacement therapy. All six had severe hy-

potension, and peripheral ischemia developed in one patient to the extent that surgical treatment was required.

Analysis of the infused TGN1412 has, to this point, indicated that it met the specifications of the manufacturer — that is, it was sterile and

pyrogen-free and contained the expected amount of protein without contaminants. Thus, the response observed is likely to represent a clear ex-

ample of an iatrogenic “cytokine storm” without the background of another illness. On the basis of the experimental data that had been gathered

before the testing of this monoclonal antibody in humans, the biologic and subsequent physiological changes were unexpected. Also in this

issue of the Journal, Sharpe and Abbas speculate on the biologic events that occurred when the patients received this treatment.

Although the data clearly show the occurrence of a cytokine storm, research is ongoing to determine exactly what happened and why. We await those results.

All six volunteers, who subsequently became patients, survived in part because of the extraordinary intensive care delivered during the critical stages of their illness. The routine treatment of such severe illness reflects a remarkable development in critical care medicine, made possible in part by the countless patients who had previ-

ously put themselves at risk as each piece of the critical-illness puzzle was dissected.

While biologists are at work trying to understand the sequence of events that led to the clinical changes seen in these volunteers, regulators

are at work trying to retool the system to minimize the possibility that such unexpected events will ever recur. It is certainly possible to change

the way in which novel agents are tested to minimize the number of subjects who are put at risk. As long as we continue to manipulate biology in

new ways, we probably cannot prevent all such events from occurring. We must do what we can to minimize risk, but the future health of the

world population demands that we not let adverse events put an end to medical progress. We must treat those at risk with respect and great

care, but the work must go on. The troubling fact of the matter is that without people who are willing to place themselves at risk to advance our

knowledge, we will be frozen in our current state of understanding. And this state simply may not be good enough to enable us to meet the next

unexpected challenge that comes our way.

This article was published at www.nejm.org on August 14, 2006.

Suntharalingam G, Perry MR, Ward S, et al. Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412.

N Engl J Med 2006;355:1018-28.

Sharpe AH, Abbas AK. T-cell costimulation — biology, therapeutic potential, and challenges. N Engl J Med 2006;355: 973-5.

Anuncios

Una respuesta to “Un aporte de Leila Mir Candal”

  1. alcohol teenagers Says:

    Hiya very cool blog!! Man .. Excellent .. Amazing .

    . I’ll bookmark your website and take the feeds additionally? I am satisfied to seek out numerous useful information here in the submit, we want work out more techniques in this regard, thank you for sharing. . . . . .

Responder

Introduce tus datos o haz clic en un icono para iniciar sesión:

Logo de WordPress.com

Estás comentando usando tu cuenta de WordPress.com. Cerrar sesión / Cambiar )

Imagen de Twitter

Estás comentando usando tu cuenta de Twitter. Cerrar sesión / Cambiar )

Foto de Facebook

Estás comentando usando tu cuenta de Facebook. Cerrar sesión / Cambiar )

Google+ photo

Estás comentando usando tu cuenta de Google+. Cerrar sesión / Cambiar )

Conectando a %s


A %d blogueros les gusta esto: